Peptide receptor targeted radiotherapy involves delivering toxic radiotherapy to tumour cells by binding a radioactive molecule to somatostatin analogues, which in turn bind to receptors located on pancreatic neuroendocrine tumours (PNETs).
All content and media on the HealthEngine Blog is created and published online for informational purposes only. It is not intended to be a substitute for professional medical advice and should not be relied on as health or personal advice. Always seek the guidance of your doctor or other qualified health professional with any questions you may have regarding your health or a medical condition. Never disregard the advice of a medical professional, or delay in seeking it because of something you have read on this Website. If you think you may have a medical emergency, call your doctor, go to the nearest hospital emergency department, or call the emergency services immediately.
